© 2002 Journal of Clinical Pathology
CASE REPORT
Anaplastic lymphoma kinase (ALK) protein expressing lymphoma after liver transplantation: case report and literature review
1 Department of Pathology, Hôpital Gui de Chauliac, 34295 Montpellier, France
2 Department of Liver Transplantation, Hôpital Saint Eloi, 34295 Montpellier, France
3 Department of Pathology and UPR CNRS 2163, Hôpital Purpan, Toulouse, France
Correspondence to:
Correspondence to:
Dr V Costes-Martineau, Department of Pathology, Hôpital Gui de Chauliac, 34295 Montpellier Cedex 5, France;
v-costes_martineau{at}chu-montpellier.fr
Most post transplantation lymphoproliferative disorders (PTLDs) are Epstein-Barr virus (EBV) associated B cell proliferations. We report a case of aggressive anaplastic large cell lymphoma expressing the anaplastic lymphoma kinase (ALK) protein in a 58 year old man who had previously undergone liver transplantation. A definite diagnosis was not possible on histopathological examination. Immunostaining clearly showed a predominant population of small irregular lymphocytes, admixed with large cells strongly positive for CD30, epithelial membrane antigen, and the ALK protein. Neoplastic cells were of the T/cytotoxic phenotype. In situ hybridisation with EBV encoded early RNA probes showed only a few scattered positive non-neoplastic small lymphocytes. Polymerase chain reaction analysis of immunoglobulin and T cell receptor rearrangements was negative. The NPMALK fusion transcript associated with the t(2;5) translocation was detected by reverse transcription polymerase chain reaction. A review of the literature revealed 76 cases of T cell PTLD, showing a broad spectrum of morphological features and clinical behaviour. Most of these cases were EBV negative (61 of 76) and occurred after renal transplantation (48 of 76). To our knowledge, this is the first case of ALK positive lymphoma occurring in the setting of organ transplantation. This observation stresses the need for accurate immunostaining for diagnosing this rare, apparently aggressive, lymphoma in immunosuppressed patients.
Keywords: ALK+ lymphoma; immunohistochemistry; liver transplantation
Abbreviations: ALK, anaplastic lymphoma kinase; EBV, Epstein-Barr virus; HTLV, human T cell lymphotropic virus; NPM, nucleophosmin; PCR, polymerase chain reaction; PTLD, post transplantation lymphoproliferative disorders
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Mahesha, V, Joshi, K, Jha, V, Nada, R
(2007). Primary cardiac post-transplantation lymphoproliferative disorder--T cell type: a case report and review of the literature. J. Clin. Pathol.
60: 447-448
[Full Text] -
Jacobsen, E.
(2006). Anaplastic Large-Cell Lymphoma, T-/Null-Cell Type. The Oncologist
11: 831-840
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
